Airway Management Devices Market Size is expected to expand at a rapid pace from 2022 to 2028, on account of the rising burden of respiratory ailments like COPD and asthma. COPD is the third leading cause of disease-related death in the United States, making airway management an essential aspect of treatment for the disease. Airway management refers to the assessment, planning, and procedures essential for the maintenance or restoration of the patients’ breathing or ventilation. Various types of airway management devices are used for opening or maintaining the airway, including NPA (nasopharyngeal airway), OPA (oropharyngeal airway), and ETA (endotracheal airway), among others.
One of the major drivers behind airway management devices market growth over 2022-2028 is technological innovations by key device manufacturers to enhance the capabilities of their products. For instance, in May 2021, Medtronic plc unveiled its first of its kind, SonarMed airway monitoring system for pediatric patients in the U.S. The device, which uses acoustic technology to detect ETT (endotracheal tube) obstructions and verify positions in real-time, is designed to give clinicians access to important data required to make more informed medical decisions. Developments such as these could contribute to a strong airway management devices market outlook over the estimated timeline.
Supraglottic devices will emerge as a prominent product segment for the airway management devices industry by 2028. This growth is credited mainly to the burgeoning demand for these products, given their beneficial attributes. SADs, for instance, are used extensively in airway algorithms worldwide, for their robust capabilities in rescue oxygenation and ventilation, as well as their crossover ability to be used as conduits for intubation.
From a regional perspective, the North America airway management devices industry is poised to depict a strong growth rate through 2028, given the robust presence of manufacturers making keen efforts to expand and commercialize their product portfolios. To illustrate, Airtraq manufacturer Prodol Meditec, SA signed an Exclusive Distribution Agreement with Mercury Medical in December 2021, appointing the latter as its distribution partner in North America for its Airtraq video laryngoscope and camera system. Developments like these could add significant impetus to regional airway management devices market expansion over the foreseeable future.
Key players operating in the global airway management devices market include Vyaire Medical, Flexicare, Ambu, Karl Storz, Intersurgical, Olympus, Medtronic, SunMed, Smiths Group, VBM Medizintechnik, Teleflex, and Verathon (Roper Technologies). Some of the major strategic initiatives being implemented by these entities include partnerships and expansions, among others. For instance, Ambu Inc announced in November 2021 that it was awarded a contract with Vizient Inc. in the Video Laryngoscopes category. Covered under the contract is the King Vision video laryngoscope system, which facilitates easier and faster intubation with a display to provide a clear and consistent view of the patient’s airway in real-time.
The onset of the COVID-19 pandemic has put immense pressure on healthcare systems across the globe, due to the sudden surge in the number of people in need of medical care. Since the coronavirus is highly transmissible via contact with infected secretions like respiratory droplets, saliva, and airborne particles, the high risk for anesthesiologists and other personnel involved in the management of patients’ airways has created challenges for the airway management devices industry, despite the growing need for respiratory solutions. However, efforts are being made worldwide to address these concerns and mitigate the risk of infection during ventilator disconnections, tracheal intubations, and extubations. One such solution has been the creation of a device by Portuguese firm Indumel in October 2021, designed specifically for clamping the ETT during these procedures, making airway management of COVID-19 patients safer for the healthcare personnel.
Market, by Device Type
Market, by End-User
The above information is provided for the following regions and countries: